X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Approach To Gene Editing For Improved Cancer Treatment

    Report Predicts OSD Contract Manufacturing Market Growth

    Driving Factors Behind Digital Bioprocessing Market Growth

    FDA Draft Guidance Supports Decentralized Clinical Trials

    Pharma Industry Groups Criticise Proposed EU Drug Regulation

    Phase I Trial of The South Korean DuoChol Vaccine In Sweden

    EU Drug Manufacturing Law Changes Disappoint Manufacturers

    AMR Is The Main Focus of New Research Consortium In World

    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Gene Silencing Alzheimers Drug, A World First, Shows Promise

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    New Approach To Gene Editing For Improved Cancer Treatment

    Report Predicts OSD Contract Manufacturing Market Growth

    Driving Factors Behind Digital Bioprocessing Market Growth

    FDA Draft Guidance Supports Decentralized Clinical Trials

    Pharma Industry Groups Criticise Proposed EU Drug Regulation

    Phase I Trial of The South Korean DuoChol Vaccine In Sweden

    EU Drug Manufacturing Law Changes Disappoint Manufacturers

    AMR Is The Main Focus of New Research Consortium In World

    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Gene Silencing Alzheimers Drug, A World First, Shows Promise

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development FDA Approvals

FDA Draft Guidance Supports Decentralized Clinical Trials

Content Team by Content Team
6th May 2023
in FDA Approvals, News

US Food and Drug Administration has come up with a novel draft guidance in order to further support the use of decentralised clinical trials when it comes to drugs, biologics, and devices. The publication has in it recommendations from investigators, sponsors, as well as other stakeholders when it comes to the implementation of DCTs so as to advance medical product development as well as research.

Under decentralised clinical trials, some or all of the clinical trial activities appear at locations other than the traditional sites. Instances of these activities include getting laboratory tests done at a local facility rather than going to a research medical centre or conducting a clinical follow-up visit at the trial participant’s home by way of telemedicine.

By reducing the hurdles to participation, the FDA expects that the decentralised clinical trials will enhance the range and diversity of the participants and also improve accessibility for those who have rare diseases or are suffering from mobility challenges. All said and done, the regulatory body thinks that the approach will result in enhanced treatment options and better patient outcomes.

As per the FDA, the new draft guidance when it comes to the DCTs goes on to cover recommendations on topics such as:

  • Considerations related to DCT design.
  • Conduct of the remote-control trial visits as well as activities related to DCTs.
  • Usage of digital health technology so as to remotely acquire the data.
  • Responsibilities as well as the role of the sponsors and investigators conducting the DCT.
  • Getting informed consent (IC) and an oversight from the institutional review board of the process of IC within the DCT.
  • Determining the appropriateness of the investigational products in terms of their use in a DCT.
  • Investigational product packaging and shipping in a DCT.
  • Monitoring the safety of DCT enrolees.

The draft guidance goes on to build on the recommendations that were published by the agency in 2020. These earlier recommendations did give clarity to the investigators so as to facilitate trial decentralisation in response to the pandemic, thereby helping to overcome barriers such as site closures and travel limitations.

According to Dr. Robert M. Califf, the progress in digital health tech and the COVID-19 pandemic, during which in-person visits were limited or in fact unavailable for many participants, have gone on to accelerate the widespread adoption of these activities. It should be taken into account that the FDA’s regulatory requirements in terms of medical product investigations for DCT as well as traditional site-based clinical trials happen to be the same.

Previous Post

Pharma Industry Groups Criticise Proposed EU Drug Regulation

Next Post

Harnessing Blockchain Technology For Better Pharma Functions

Related Posts

News

New Approach To Gene Editing For Improved Cancer Treatment

6th May 2023
Drug Development

Report Predicts OSD Contract Manufacturing Market Growth

6th May 2023
Drug Development

Driving Factors Behind Digital Bioprocessing Market Growth

6th May 2023
IPR Data Management

Harnessing Blockchain Technology For Better Pharma Functions

6th May 2023
Drug Development

Pharma Industry Groups Criticise Proposed EU Drug Regulation

4th May 2023
Manufacturing

EU States Seek Reduced Reliance On Chinese Pharma Imports

4th May 2023
Next Post

Harnessing Blockchain Technology For Better Pharma Functions

Latest News

News

New Approach To Gene Editing For Improved Cancer Treatment

6th May 2023
Drug Development

Report Predicts OSD Contract Manufacturing Market Growth

6th May 2023
Drug Development

Driving Factors Behind Digital Bioprocessing Market Growth

6th May 2023
IPR Data Management

Harnessing Blockchain Technology For Better Pharma Functions

6th May 2023
FDA Approvals

FDA Draft Guidance Supports Decentralized Clinical Trials

6th May 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In